Impact of hepatitis B on mortality and specific causes of death in adults with and without HIV co-infection in NYC, 2000-2011
- PMID: 27510414
- PMCID: PMC9150190
- DOI: 10.1017/S0950268816001801
Impact of hepatitis B on mortality and specific causes of death in adults with and without HIV co-infection in NYC, 2000-2011
Abstract
High rates of immigration from endemic countries contribute to the high chronic hepatitis B (HBV) prevalence in New York City (NYC) compared to the United States overall, i.e. about 1 million individuals. We describe the impact of HBV infection on mortality and specific causes of death in NYC. We matched surveillance and vital statistics mortality data collected from 2000 to 2011 by the New York City Department of Health and Mental Hygiene (DOHMH) and analysed demographics and premature deaths (i.e. whether death occurred at <65 years) in persons with and without chronic HBV or HIV infection (excluding those with hepatitis C). From 2000 to 2011, a total of 588 346 adults died in NYC. Of all decedents, 568 753 (97%) had no report of HIV or HBV, and 4346 (0·7%) had an HBV report. Of HBV-infected decedents, 1074 (25%) were HIV co-infected. Fifty-five percent of HBV mono-infected and 95% of HBV/HIV co-infected decedents died prematurely. HBV disproportionately impacts two subgroups: Chinese immigrants and HIV-infected individuals. These two subgroups are geographically clustered in different neighbourhoods of NYC. Tailoring prevention and treatment messages to each group is necessary to reduce the overall burden of HBV in NYC.
Keywords: HIV/AIDS; Hepatitis B; mortality; surveillance.
Figures


Similar articles
-
HIV and viral hepatitis co-infection in New York City, 2000-2010: prevalence and case characteristics.Epidemiol Infect. 2015 May;143(7):1408-16. doi: 10.1017/S0950268814002209. Epub 2014 Aug 29. Epidemiol Infect. 2015. PMID: 25170631 Free PMC article.
-
Estimating the prevalence of chronic hepatitis B virus infection--New York City, 2008.J Urban Health. 2012 Apr;89(2):373-83. doi: 10.1007/s11524-011-9653-7. J Urban Health. 2012. PMID: 22246675 Free PMC article.
-
Effect of Hepatocellular Carcinoma on Mortality Among Individuals With Hepatitis B or Hepatitis C Infection in New York City, 2001-2012.Open Forum Infect Dis. 2018 Jun 16;5(7):ofy144. doi: 10.1093/ofid/ofy144. eCollection 2018 Jul. Open Forum Infect Dis. 2018. PMID: 30019001 Free PMC article.
-
Insights into human immunodeficiency virus-hepatitis B virus co-infection in India.World J Virol. 2015 Aug 12;4(3):255-64. doi: 10.5501/wjv.v4.i3.255. World J Virol. 2015. PMID: 26279986 Free PMC article. Review.
-
Hepatitis B and human immunodeficiency virus co-infection.World J Gastroenterol. 2014 Dec 14;20(46):17360-7. doi: 10.3748/wjg.v20.i46.17360. World J Gastroenterol. 2014. PMID: 25516647 Free PMC article. Review.
Cited by
-
A long-acting 3TC ProTide nanoformulation suppresses HBV replication in humanized mice.Nanomedicine. 2020 Aug;28:102185. doi: 10.1016/j.nano.2020.102185. Epub 2020 Mar 24. Nanomedicine. 2020. PMID: 32217146 Free PMC article.
-
Molecular Identification of HIV-1 in the Presence of Hepatitis B Virus and Hepatitis C Virus Co-infections.Balkan Med J. 2020 Apr 10;37(3):125-130. doi: 10.4274/balkanmedj.galenos.2020.2019.5.89. Epub 2020 Feb 28. Balkan Med J. 2020. PMID: 32106666 Free PMC article.
-
Prevalence of sero-markers and non-invasive assessment of liver cirrhosis in patients with Hepatitis B virus infection in Freetown, Sierra Leone: a cross-sectional study.BMC Gastroenterol. 2021 Aug 9;21(1):320. doi: 10.1186/s12876-021-01892-5. BMC Gastroenterol. 2021. PMID: 34372775 Free PMC article.
-
Factors Associated with Hepatitis B and C Co-Infection among HIV-Infected Patients in Singapore, 2006-2017.Trop Med Infect Dis. 2019 May 27;4(2):87. doi: 10.3390/tropicalmed4020087. Trop Med Infect Dis. 2019. PMID: 31137801 Free PMC article.
-
HBcAb seropositivity is correlated with poor HIV viremia control in an Italian cohort of HIV/HBV-coinfected patients on first-line therapy.Sci Rep. 2019 Aug 16;9(1):11942. doi: 10.1038/s41598-019-46976-1. Sci Rep. 2019. PMID: 31420570 Free PMC article.
References
-
- NYC DOHMH. Hepatitis B and C surveillance report: New York City 2013. New York, NY: New York City Department of Health and Mental Hygiene, Division of Disease Control, Bureau of Communicable Diseases, 2015.
-
- WHO. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva, Switzerland, 2015. - PubMed
-
- CDC. Surveillance of viral hepatitis – United States, 2013. United States: Centers for Disease Control and Prevention, Hepatitis DoV, 20 July 2013, 2015 (http://www.cdc.gov/hepatitis/statistics/2013surveillance/pdfs/2013hepsur...).
-
- Stasi C, et al. The epidemiological changes of HCV and HBV infections in the era of new antiviral therapies and the anti-HBV vaccine. Journal of Infection and Public Health 2016; 9: 389–395. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources